Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.480
+0.185 (8.06%)
At close: Mar 9, 2026, 4:00 PM EDT
2.490
+0.010 (0.40%)
After-hours: Mar 9, 2026, 5:56 PM EDT
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 166 employees as of December 31, 2024. The number of employees decreased by 2 or -1.19% compared to the previous year.
Employees
166
Change (1Y)
-2
Growth (1Y)
-1.19%
Revenue / Employee
$161,837
Profits / Employee
-$899,494
Market Cap
161.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Sangamo Therapeutics | 183 |
| Innate Pharma | 174 |
| Fate Therapeutics | 161 |
| Artiva Biotherapeutics | 106 |
| Rani Therapeutics Holdings | 106 |
| Immunic | 90 |
| Connect Biopharma Holdings | 62 |
ZNTL News
- 19 days ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026 - GlobeNewsWire
- 3 months ago - Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market - Seeking Alpha
- 4 months ago - Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire
- 4 months ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 6 months ago - Zentalis Pharmaceuticals, Inc. (ZNTL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha